Olverembatinib dimesylate T2429
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
GZD824 Dimesylate is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I).
CAS nr:
1421783-64-3
Purity:
98%
Molecular Weight:
724,77
SMILES:
CS(=O)(=O)O.CS(=O)(=O)O.CN1CCN(Cc2c(cc(NC(=O)c3cc(C#Cc4cc5c([nH]nc5)nc4)c(C)cc3)cc2)C(F)(F)F)CC1
Formula:
C29H27F3N6O�2CH4O3S
Pathway:
Angiogenesis,Tyrosine Kinase/Adaptors,Cytoskeletal Signaling
Target:
Bcr-Abl,Bcr-Abl,Bcr-Abl
